Articles

Transducin β-like protein 1 controls multiple oncogenic networks in diffuse large B-cell lymphoma

Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University, Columbus, OH
Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, OH
Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
Department of Cancer Biology and Genetics, The Ohio State University Columbus, OH, USA.; Department of Surgery, Division of Surgical Oncology, The Ohio State University Columbus, OH
Department of Biomedical Informatics, The Ohio State University, Columbus, OH
Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
Department of Pathology, Division of Hematopathology, Duke University, Durham, NC
Department of Pathology, Division of Hematopathology, Duke University, Durham, NC
Department of Pathology, Division of Hematopathology, Duke University, Durham, NC
Iterion Therapeutics, Huston, TX
Department of Translational Neurosciences and Neurotherapeutics, John Wayne Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA
Discovery Life Sciences, Powell, OH, USA.
Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
Haematologica Early view Sep 14, 2020 https://doi.org/10.3324/haematol.2020.268235